Molecular Neuromodulation
41 – 50 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor
(
- Contribution to journal › Article
- 2014
-
Mark
Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons.
(
- Contribution to journal › Article
-
Mark
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
(
- Contribution to journal › Article
- 2013
-
Mark
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
- 2012
-
Mark
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Gene therapy for Parkinson's disease shows promise.
(
- Contribution to journal › Article
- 2010
-
Mark
Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates
(
- Contribution to journal › Article
-
Mark
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease.
(
- Contribution to journal › Article